Skip to content

Feasibility of efficacy and safety of double-tract reconstruction after laparoscopic proximal gastrectomy for gastric cancer: a phase II study

Feasibility of efficacy and safety of double-tract reconstruction after laparoscopic proximal gastrectomy for gastric cancer: a phase II study - LPG double tract

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036675
Enrollment
22
Registered
2019-05-08
Start date
2018-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer in the upper third

Interventions

Laparoscopic proximal gastrectomy with double-tract reconstruction

Sponsors

Wakayama Medical University, School of Medicine, Second Department of Surgery
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Histologically proven gastric carcinoma in the upper third 2. Performance status 0 and 1 3. Aged 20 to 85 year 4. No history of surgery for gastric cancer (Endoscopic treatment is tolerant) 5. Plt => 100,000/mm3 Creatinine <= 2.0 mg/dl AST <= 200 IU/L ALT <= 200 IU/L T-bil <= 2.0 mg/dl Hb => 8.0 g/dl 6. Patients who gave written informed consent before entry in this study

Exclusion criteria

Exclusion criteria: 1. Ischemic heart disease 2. Liver cirrhosis, active hepatitis 3. Interstitial pneumonia 4. Haemodialysis 5. Both malignant disorder 6. Severe abdominal adhesion 7. Doctor's decision not to register to this regimen

Design outcomes

Primary

MeasureTime frame
Weight loss rate 6 months after surgery

Secondary

MeasureTime frame
Surgical process (operative time, intraoperative bleeding, the number of ports, the use of the saturation, cost, the rates of laparotomy transition), postoperative course (oral intake, length of stay, inflammatory findings, the rates of late complications, stenosis, usage rate of PPI, incidence rate of GERD).

Countries

Japan

Contacts

Public ContactToshiyasu Ojima

Wakayama Medical University School of Medicine Second Department of Surgery

tojima@wakayama-med.ac.jp0734410613

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026